ServiziMenu principaleHome
You are here: Home > Events > Future Events > 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology


Chairs: A. Eniu, RO - C. Zielinski, AT
Host chair: E. Vrdoljak, HR
ESO Masterclass Coordinator: N. Pavlidis, GR

This residential programme has been designed for medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology.
The programme focuses on cancer pathology and molecular biology, pharmacology of anti-cancer drugs and on frequent cancers such as breast, lung, gastro-intestinal, gynaecological and head and neck cancer. Spotlight sessions will provide inside on state of the art approaches in melanoma, sarcoma, thyroid cancer and on palliative care. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion.
All participants will reside at the Masterclass venue and participation is mandatory throughout the course. At the end of each of the five days a learning self-assessment discussion with the chair of the course will be provided.

• To update the knowledge on basic science of clinical and medical oncology
• To enhance the competence and practical performance in systemic therapy of malignancies
• To enhance the competence and practical performance in multidisciplinary cancer care
• To update knowledge and get additional skills in supportive as well as palliative care
• To prepare for the board exam in clinical/medical oncology

• A five day residential, educational event
• Full immersion
• Clinically oriented
• Multidisciplinary

• Cancer biology/pathology
• Cancer genetics
• Pharmacology of anti-cancer drugs
• Breast cancer
• Gastro-intestinal tumours
• Gynaecological tumours
• Symptom management in gynaecological cancers
• Head and neck cancers
• Lung cancer and mesothelioma
• Genito-urinary cancers
• Palliative and supportive care
• Haematological malignancies

The Eastern Europe
and Balkan Region Masterclass in
Medical Oncology is an
ESO-ESMO joint event


In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

Download PDF document


FACULTY (as of September 2019)
J. Beyer, University Hospital Zürich, CH
S. Bosnjak, Institute of Oncology and Radiology of Serbia, Belgrade, RS
E. Brain, Marie Curie Institute, Paris, FR
M.J. Cardoso, Champalimaud Cancer Center, Lisbon, PT
S. Cascinu, Università di Modena e Reggio Emilia, Modena, IT
T. Cufer, University Clinic Golnik, Golnik, SI
O. Dafni, National and Kapodistrian University of Athens, Athens, GR
A. Eniu, Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO
F.B. Geara, American University of Beirut Medical Center, Beirut, LB
M. Halaska, Charles University, Prague, CZ
M.A. Hoda, Medical University Vienna, Vienna, AT
D. Jovanovic, Clinical Center of Serbia, Belgrade, RS
I. Kern, University Clinic Golnik, Golnik, SI
S. Martin Algarra, University Clinic of Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, ES
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, University Hospital of Ioannina, GR
R. Popescu, Hirslanden Klinik Aarau, CH
M. Porebiak, SWPS University of Social Sciences and Humanities, Warsaw, PL
C. Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
C. Sotiriou, Institut Jules Bordet, Brussels, BE
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Tomic, Clinical Institute of Pathology KBC Split, Split, HR
J.B. Vermorken, Antwerp University Hospital, Edegem, BE
E. Vrdoljak, Clinical Hospital Split, Medical School Split, Split, HR
C. Zielinski, Comprehensive Cancer Center Vienna, Vienna, AT

General information

Dolores Knupfer
European School of Oncology - Bellinzona Office
Piazza Indipendenza 2
CH 6500 Bellinzona - Switzerland
Tel: +41 91 820 0952
Fax: +41 91 820 0953
Email: dknupfer@eso.net

The Masterclass will be held in English and translation will not be provided.

The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.

The 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The programme has been granted up to 26 European CME credits (ECMEC) . Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
The programme has also been submitted to ESMO for ESMO-MORA accreditation.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.


• Age between 30 and 40 years
• 2-3 years’ experience in oncology
• Involvement in scientific activities and clinical trials
• Fluency in English

Admittance to the Masterclass is by competitive application. The successful applicants are granted free registration, full board, airport transfer to the course venue and accommodation in Vodice for the period 14-19 May 2020. Travel will be covered by the participants.
All participants will be expected to reside at the course venue and their full participation is compulsory throughout the course.
The Masterclass will be taught entirely in English and fluency in English is necessary for admission.

Interested oncologists should apply online (at the top of this page) providing:

• Letter describing motivation for attending the Masterclass
• Short CV (maximum 2 pages) with a list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)
• Supporting letter from Head of Department/Mentor
• Abstract with proposed presentation of a clinical case relating to one of the main themes of the Masterclass (Breast Cancer, Gastro-intestinal cancers, Genito-urinary cancers, Gynaecological tumours, Sympton management of gynaecological tumours, Head and neck cancer, Lung and mesothelioma)

The abstract should be presented in the form of a grand-round clinical discussion rather than a publication report, and describe:

• Diagnostic considerations
• Treatment
• Outcome (follow-up)
• Up to three questions that the author proposes for discussion by the faculty and participants

Candidates should avoid the selection of very rare or unusual cases and try to find clinical situations more likely to be encountered in day to day practice.

Priority will be given to candidates practicing in Eastern Europe and Balkan region countries.

Successful applicants are granted free registration and accommodation

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Abstract template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

• Download HERE your Professional experience template
•  Download HERE your Abstract template


14 May

18:00   Registration
18:30   Welcome address and general introduction
A. Eniu, RO - N. Pavlidis - GR, E. Vrdoljak, HR
18:45   Access to care: an old/new issue? Global and Eastern European issues
A. Eniu, RO
19:05   Discussion
19:15   Access to diagnoses and drugs in NSCLC in central and southeastern Europe
T. Cufer, SI
19:35   Discussion
20:00   Dinner    


 15 May

Chairs: J. Beyer, CH - F.B. Geara, LB  
 9:00   Local therapy for prostate cancer
(surgery and radiotherapy)

F.B. Geara, LB
 9:20   Discussion
 9:30   Metastatic prostate cancer
J. Beyer, CH
 9:50   Discussion
 10:00   Testicular cancer
J. Beyer, CH
 10:20   Discussion   
 10:30   Systemic treatment of advanced renal cancer
J. Beyer, CH
 10:50   Discussion
 11:00   Coffee break
11:30   Tumor board on genito-urinary tumours
 12:30   Lunch
 13:30   How to prepare and deliver a successful public presentation
J. Beyer, CH
 13:50   Discussion
 14:00   Statistics in oncology, critical reading clinical trials design and publications…
O. Dafni, GR
 14:25   Discussion
14:30   Coffee break
15:00   IPOS lecture: Communication skills as first level psycho-social care
M. Porebiak, PL
15:30   Discussion
(3 groups in parallel, 15 cases)
T. Cufer, SI - A. Eniu, RO - R. Popescu, CH - N. Pavlidis, GR
 20:00   Dinner


 16 May

Chairs: T. Cufer, SI - E. Vrdoljak, HR  
8:30   Breast cancer pathology and molecular biology
S.Tomic, HR
8:50   Discussion         
9:00   Optimal surgical management of breast cancer
M.J. Cardoso, PT
9:20   Discussion  
9:30   The role of radiotherapy in early and advanced BC
E. Vrdoljak, HR
9:50   Discussion
10:00   Coffee break
10:30   Optimal approach in locally advanced disease: ESO-ESMO ABC Guidelines
A. Eniu, RO
10:50   Discussion   
 11:00   Systemic treatment of luminal early and advanced breast cancer
A. Eniu, RO
 11:20   Discussion   
 11:30   Systemic treatment of HER2-positive early and advanced BC
T. Cufer, SI      
  Systemic treatment of TN early and advanced BC
C. Sotiriou, BE
 12:20   Discussion
12:30   Cancer genetics for the practising oncologist
C. Sotiriou, BE
12:50   Discussion
 13:00   Lunch
 14:30   Advances in the management of non-Hodgkin's lymphoma
A. Stathis, CH
 14:50   Discussion
 15:00   Management of cancer in the elderly
E. Brain, FR
 15:20   Discussion
15:30   Coffee break
16:00   Tumor board on breast cancer
 19:00   Dinner


 17 May

Chairs: S. Cascinu, IT - D. Papamichael, CY
8:30   Adjuvant/neoadjuvant systemic treatment of colorectal cancer
D. Papamichael, CY
8:50   Discussion
9:00   Systemic treatment of advanced colorectal cancer
D. Papamichael, CY
9:20   Discussion
9:30   Coffee break
10:00   Optimal management of metastatic gastric cancer in 2020  
S. Cascinu, IT
10:20   Discussion
10:30   Adjuvant/neo-adjuvant therapy in GEJ/Stomach adenocarcinoma 
S. Cascinu, IT
10:50   Discussion
11:00   Tumour board on gastro-intestinal tumours
S. Cascinu, IT - D. Papamichael, CY
12:00   Lunch
Chair: C. Sessa, CH
13:00   Screening of cervical cancer
C. Sessa, CH
13:30   Discussion
13:40   Role of surgery in gynaecological cancer
M. Halaska, CZ
14:10   Discussion
14:20   Systemic management of ovarian cancer
J.B. Vermorken, BE
14:50   Discussion
15:00   Systemic management of cervical and endometrial
C. Sessa, CH
15:50   Discussion
16:00   Coffee break
16:15   Tumor board on gynaecological tumours 
17:00   Therapeutic management of head and neck cancers
J.B. Vermorken, BE
17:30   Discussion
17:40   Tumour board on head and neck cancers
J.B. Vermorken, BE
20:00   Dinner


18 May

Chairs: T. Cufer, SI, D. Jovanovic, RS
9:00   Lung cancer pathology and molecular biology
I. Kern, SI
9:20   Discussion
9:30   Surgery for lung cancer and malignant pleural mesothelioma M.A. Hoda, AT
9:50   Discussion
10:00   Optimal management of stage III disease D. Jovanovic, RS
10:30   Coffee break
11:00   Targeted agents in NSCLC cancer
T. Cufer, SI
11:20   Discussion
11:30   Standard of care of SCLC and future directions
D. Jovanovic, RS
11:50   Discussion
12:00   Systemic management of mesothelioma
D. Jovanovic, RS
12:20   Discussion
12:30   The diagnostic and therapeutic management of Cancer of Unknown Primary
N. Pavlidis, GR
12:50   Discussion
13:00   Lunch
14:15   Tumor board on lung cancer
15:15   Systemic management of pancreatic cancer
R. Popescu, CH
15:35   Discussion
15:45   Benefits of early integration of cancer care and palliative care
S. Bosnjak, RS
16:05   Discussion
16:15   Supportive care
S. Bosnjak, RS
16:35   Discussion
16:45   Coffee break
(3 groups in parallel, 15 cases)
N. Pavlidis, GR - R. Popescu, CH - C. Zielinski, AT


 19 May

9:00   Management of melanoma with immunotherapy and targeted treatment
S. Martin-Algarra, ES
9:20   Discussion
9:30   Learning self-assessment test
10:20   Immune check point inhibitors: Immunologic background, indications and innovations
C. Zielinski, AT
10:50   Discussion
 11:00   Close
 11:30   Standing lunch and departures


Follow us